GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.611 $0.83 Thursday, 18th Apr 2024 ATRA stock ended at $0.692. This is 3.25% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.25% from a day low at $0.690 to a day high of $0.740.
90 days $0.569 $1.58
52 weeks $0.199 $3.06

Historical Atara Biotherapeutics prices

Date Open High Low Close Volume
2024-04-18 $0.719 $0.740 $0.690 $0.692 819 302
2024-04-17 $0.676 $0.730 $0.676 $0.715 827 765
2024-04-16 $0.680 $0.722 $0.656 $0.682 1 021 189
2024-04-15 $0.710 $0.710 $0.650 $0.679 1 718 853
2024-04-12 $0.712 $0.740 $0.700 $0.708 1 161 909
2024-04-11 $0.734 $0.747 $0.710 $0.713 367 128
2024-04-10 $0.730 $0.751 $0.690 $0.718 639 824
2024-04-09 $0.763 $0.770 $0.740 $0.749 681 230
2024-04-08 $0.771 $0.81 $0.750 $0.756 1 164 814
2024-04-05 $0.780 $0.83 $0.735 $0.774 1 192 207
2024-04-04 $0.735 $0.83 $0.725 $0.779 1 860 813
2024-04-03 $0.708 $0.740 $0.696 $0.720 787 611
2024-04-02 $0.732 $0.749 $0.680 $0.728 1 504 681
2024-04-01 $0.714 $0.733 $0.690 $0.725 1 317 747
2024-03-28 $0.665 $0.720 $0.648 $0.694 1 188 169
2024-03-27 $0.680 $0.719 $0.649 $0.700 1 038 081
2024-03-26 $0.670 $0.680 $0.619 $0.661 1 390 877
2024-03-25 $0.721 $0.750 $0.660 $0.670 1 469 002
2024-03-22 $0.706 $0.710 $0.659 $0.697 1 064 850
2024-03-21 $0.730 $0.752 $0.660 $0.669 1 650 838
2024-03-20 $0.690 $0.740 $0.650 $0.720 1 362 221
2024-03-19 $0.620 $0.688 $0.611 $0.683 1 303 000
2024-03-18 $0.635 $0.635 $0.591 $0.596 1 210 207
2024-03-15 $0.620 $0.655 $0.615 $0.621 1 463 746
2024-03-14 $0.665 $0.665 $0.621 $0.630 1 853 879
Click to get the best stock tips daily for free!

About Atara Biotherapeutics

Atara Biotherapeutics Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT